Epistatic modifiers of autoimmunity in a murine model of lupus nephritis

被引:150
|
作者
Morel, L [1 ]
Tian, XH
Croker, BP
Wakeland, EK
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Ctr Mammalian Genet, Gainesville, FL 32610 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1074-7613(00)80088-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sle1 and Sle3 are NZW-derived loci that mediate lupus nephritis on a C57BL/6 background. The absence of severe autoimmunity in NZW suggests that the NZW genome suppresses these genes. (B6.NZMc1[Sle1] x NZW)F1 hybrids develop severe humoral autoimmunity and fatal lupus nephritis, indicating that suppression of Sle1 from NZW is recessive. Linkage analysis identified four epistatic modifiers, Sles1-4, whose cumulative effect accounted for the benign autoimmunity in NZW. The specific suppression of Sle1 but not Sle2 or Sle3 by Sles1 was directly demonstrated via the production and analysis of bicongenic strains. Moreover, Sles1 was sufficient to completely suppress autoimmunity initiated by Sle1 in B6.NZMc1 x NZW hybrids. These results demonstrate the complex epistatic interactions of loci augmenting and suppressing systemic autoimmunity.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [41] Disease Progression Is Altered By Moderate Exercise and Social Stress in a Murine Model of Lupus Nephritis
    Hampton, Jeffrey
    Young, Nicholas A.
    Agarwal, Sudha
    Aqel, Saba
    Jones, Kendra
    Wu, Lai-Chu
    Powell, Nicole
    Sheridan, John
    Bruss, Michael
    Jarjour, Wael N.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis
    Liu, Qingjuan
    Du, Yunxia
    Li, Kejun
    Zhang, Wei
    Feng, Xiaojuan
    Hao, Jun
    Li, Hongbo
    Liu, Shuxia
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [43] Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis
    Young, Nicholas A.
    Jablonski, Kyle
    Schwarz, Emmy
    Okafor, Ifeoma
    Hampton, Jeffrey
    Valiente, Giancarlo R.
    Henry, Caitlin
    Harb, Peter
    Barger, Jessica
    Bratasz, Anna
    Kalyanasundaram, Anuradha
    Ardoin, Stacy P.
    Jarjour, Wael N.
    LUPUS, 2020, 29 (13) : 1790 - 1799
  • [44] The TNF-family cytokine receptor death-receptor 3 (TNFRSF25) is required for nephritis but not systemic autoimmunity in the Ipr murine model of lupus
    Hayes, Erika
    Villarreal, Sarah
    Ferdinand, John
    Engel, Odile
    Meylan, Francoise
    Siegel, Richard
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [45] B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity
    Chan, OTM
    Madaio, MP
    Shlomchik, MJ
    JOURNAL OF IMMUNOLOGY, 1999, 163 (07): : 3592 - 3596
  • [46] New immunosuppresor strategies in the treatment of murine lupus nephritis
    Alperovich, G.
    Rama, I.
    Lloberas, N.
    Franquesa, M.
    Poveda, R.
    Goma-i-Freixanet, M.
    Herrero-Fresneda, I.
    Cruzado, J. M.
    Bolanos, N.
    Carrera, M.
    Grinyo, J. M.
    Torras, J.
    LUPUS, 2007, 16 (01) : 18 - 24
  • [47] Chemokines and cytokines during the development of murine lupus nephritis
    Silveira, K.
    Simes e Silva, A. C.
    Teixeira, M.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1598 - 1598
  • [48] Chromatin as a target antigen in human and murine lupus nephritis
    Annica Hedberg
    Elin S Mortensen
    Ole P Rekvig
    Arthritis Research & Therapy, 13
  • [49] MURINE LUPUS NEPHRITIS - A STRUCTURE-FUNCTION STUDY
    KIBERD, BA
    LABORATORY INVESTIGATION, 1991, 65 (01) : 51 - 60
  • [50] EFFECT OF CYCLOPHOSPHAMIDE (CY) ON IMMUNOREACTANTS OF MURINE LUPUS NEPHRITIS
    CAVALLO, T
    GRAVES, K
    GRANHOLM, NA
    KIDNEY INTERNATIONAL, 1984, 25 (01) : 221 - 221